Dark
Light
Today: October 4, 2024
March 20, 2024
1 min read

BCapital Raises $750M for New Opportunities Fund




Article Summary

TLDR:

Key Points:

  • B Capital closes Opportunities Fund II at $750M
  • Fund will make investments in technology, healthcare, and climate tech sectors, focusing on North America and Asia

Article Summary

B Capital, a global multi-stage investment firm, has closed B Capital Opportunities Fund II, L.P. at $750 million, marking nearly double the size of its predecessor fund. The fund received strong participation from a diverse group of investors and will make primary and secondary investments in later-stage companies in the technology, healthcare, and climate tech sectors, with a focus on North America and Asia. The majority of the fund will be used for follow-on investments in existing portfolio companies, while a portion will be allocated to new investment opportunities where B Capital’s value-added approach can have an immediate impact on growth.

Raj Ganguly, Co-founder and Co-CEO of B Capital, emphasized the firm’s commitment to supporting founders and helping innovative entrepreneurs scale and build industry-leading companies. Co-founder and Co-CEO Eduardo Saverin highlighted the increased capital availability to support the best founders in the portfolio amid a challenging environment for private tech companies. The fund’s first investment was in Icertis, a contract intelligence company, showcasing B Capital’s approach to accelerating value creation through strategic partnerships and business development initiatives.

B Capital, founded in 2015, focuses on technology, healthcare, and climate tech investments and leverages its global presence and strategic partnership with the Boston Consulting Group to provide value-added support to entrepreneurs. With more than $6 billion in assets under management across various funds, B Capital aims to shape the future through technology and help exceptional companies scale efficiently and build exceptional value.


Previous Story

Billionaire Eduardo Saverin’s B Capital Raises $750M for Late-Stage Startups

Next Story

Leading US investors back Engrail Therapeutics with $157m in Series B

Latest from Blog

Go toTop